Lisa Gammalo, BA, CCRC

Lisa Gammalo, BA, CCRC, provides oversight to the Quality Management Department of Winship Cancer Institute Clinical Trial Office. Ms. Gammalo is responsible for supervision of a team that conducts clinical trial monitoring of general data quality, informed consent, eligibility, adverse events, disease assessment and treatment process for National Cancer Institute (NCI), National Clinical Trials Network (NCTN) and Experimental Therapeutics Clinical Trials Network (ETCTN) clinical trials. Ms. Gammalo is also responsible for an audit and preparation team providing project management to NCTN, ETCTN and NCI based audits as well as overseeing the Standard Operating Procedures Committee and Corrective and Preventative Action Committee.

Ms. Gammalo has extensive clinical trials experience with 20 years in the management and auditing of oncology research trials, particularly within the NCI’s NCTN program. Prior to her current role, she served as the Associate Director of Quality Management for Thermo Fisher Scientific/PPD.  Ms. Gammalo has also held prior roles as a clinical research coordinator, data coordinator, and as an internal quality assurance auditor for the Northside Hospital Clinical Research Department.